JCR Pharmaceuticals Co., Ltd.
TSE:4552.T
661 (JPY) • At close November 8, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 42,871 | 34,343 | 51,082 | 30,085 | 24,781 | 23,160 | 20,594 | 18,085.035 | 17,438.377 | 16,855.654 | 15,705.912 | 14,099.91 | 12,845.064 | 14,457.846 | 14,387.4 | 12,082.718 | 11,871.886 | 8,544.735 | 7,648.819 | 8,099.74 |
| Kosten van de omzet
| 11,620 | 8,886 | 10,461 | 7,812 | 7,901 | 6,567 | 6,128 | 5,731.719 | 6,459.424 | 5,740.928 | 5,842.081 | 5,036.939 | 4,213.016 | 5,227.348 | 4,142.465 | 3,555.732 | 3,824.724 | 2,818.303 | 2,881.399 | 3,653.64 |
| Brutowinst
| 31,251 | 25,457 | 40,621 | 22,273 | 16,880 | 16,593 | 14,466 | 12,353.316 | 10,978.953 | 11,114.726 | 9,863.831 | 9,062.971 | 8,632.048 | 9,230.498 | 10,244.935 | 8,526.986 | 8,047.162 | 5,726.432 | 4,767.42 | 4,446.1 |
| Brutowinstmarge
| 0.729 | 0.741 | 0.795 | 0.74 | 0.681 | 0.716 | 0.702 | 0.683 | 0.63 | 0.659 | 0.628 | 0.643 | 0.672 | 0.638 | 0.712 | 0.706 | 0.678 | 0.67 | 0.623 | 0.549 |
| Onderzoek- en ontwikkelingskosten
| 11,234 | 8,802 | 7,175 | 5,360 | 5,997 | 4,354 | 4,211 | 4,071.356 | 3,348.297 | 3,334 | 2,202 | 1,991 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,992 | 4,891 | 4,782 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 721 | 1,225 | 1,139 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 23,719 | 11,678 | 13,511 | 8,624 | 7,638 | 7,271 | 6,470 | 5,919.956 | 5,477.886 | 5,713 | 6,116 | 5,921 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige kosten
| 5 | 58 | 38 | 61 | 4 | 16 | 10 | 51.688 | 107.018 | 109.726 | 26.209 | 22.697 | 24.803 | 16.121 | 128.05 | 121.703 | 248.69 | -287.857 | -199.084 | -2,331.354 |
| Bedrijfskosten
| 23,719 | 20,480 | 20,686 | 14,003 | 13,635 | 11,625 | 10,681 | 9,991.312 | 8,826.182 | 9,100.125 | 8,318.362 | 7,912.05 | 7,542.281 | 7,822.914 | 8,237.308 | 7,980.515 | 7,765.196 | 5,890.004 | 4,802.787 | 3,986.597 |
| Bedrijfsresultaat
| 7,532 | 4,975 | 19,933 | 8,269 | 3,244 | 4,967 | 3,784 | 2,362.003 | 2,152.77 | 2,014.6 | 1,545.468 | 1,150.92 | 1,089.767 | 1,407.584 | 2,007.627 | 546.471 | 281.966 | -163.572 | -35.367 | 459.503 |
| Bedrijfsresultaat ratio
| 0.176 | 0.145 | 0.39 | 0.275 | 0.131 | 0.214 | 0.184 | 0.131 | 0.123 | 0.12 | 0.098 | 0.082 | 0.085 | 0.097 | 0.14 | 0.045 | 0.024 | -0.019 | -0.005 | 0.057 |
| Totaal overige inkomsten en kosten netto
| -288 | 434 | -532 | 363 | 176 | -40 | 111 | 130.785 | 306.489 | 319.711 | 131.997 | -86.131 | -147.708 | -133.519 | -423.682 | 15.654 | 154.925 | -448.207 | 74.558 | -2,387.26 |
| Inkomen voor belasting
| 7,244 | 5,412 | 19,404 | 8,653 | 3,422 | 4,928 | 3,895 | 2,492.788 | 2,459.259 | 2,334.311 | 1,677.466 | 1,064.789 | 942.059 | 1,274.065 | 1,583.945 | 562.125 | 436.891 | -611.779 | 39.191 | -1,927.757 |
| Inkomen voor belasting ratio
| 0.169 | 0.158 | 0.38 | 0.288 | 0.138 | 0.213 | 0.189 | 0.138 | 0.141 | 0.138 | 0.107 | 0.076 | 0.073 | 0.088 | 0.11 | 0.047 | 0.037 | -0.072 | 0.005 | -0.238 |
| Belastingkosten
| 1,707 | 1,625 | 4,886 | 1,764 | 742 | 1,217 | 825 | 629.517 | 669.661 | 651.892 | 381.133 | 333.951 | 308.047 | 347.508 | 279.841 | 21.198 | 34.382 | 1,139.593 | 68.981 | -658.989 |
| Nettowinst
| 5,507 | 3,772 | 14,507 | 6,892 | 2,678 | 3,715 | 3,070 | 1,863.17 | 1,789.474 | 1,682.368 | 1,296.206 | 730.715 | 633.989 | 926.473 | 1,302.874 | 539.911 | 399.972 | -1,751.061 | -31.864 | -1,272.365 |
| Nettowinstmarge
| 0.128 | 0.11 | 0.284 | 0.229 | 0.108 | 0.16 | 0.149 | 0.103 | 0.103 | 0.1 | 0.083 | 0.052 | 0.049 | 0.064 | 0.091 | 0.045 | 0.034 | -0.205 | -0.004 | -0.157 |
| WPA (Winst Per Aandeel)
| 44.13 | 30.34 | 117.26 | 55.8 | 21.72 | 30.17 | 24.68 | 14.74 | 14.03 | 13.21 | 10.2 | 5.76 | 4.94 | 7.23 | 12.69 | 5.02 | 3.69 | -15.96 | -0.5 | -16.38 |
| Verwaterde WPA
| 43.92 | 30.22 | 116.79 | 55.52 | 21.59 | 29.99 | 24.53 | 14.65 | 13.95 | 13.13 | 10.13 | 5.73 | 4.92 | 7.15 | 11.39 | 5.02 | 3.69 | -15.96 | -0.5 | -16.38 |
| EBITDA
| 10,729 | 7,479 | 22,501 | 10,462 | 4,749 | 6,411 | 5,216 | 3,945.359 | 3,729.625 | 3,586.725 | 2,836.426 | 2,185.73 | 2,164.386 | 2,347.089 | 2,673.613 | 1,399.416 | 1,159.126 | 158.637 | 375.622 | -1,316.505 |
| EBITDA ratio
| 0.25 | 0.218 | 0.44 | 0.348 | 0.192 | 0.277 | 0.253 | 0.218 | 0.214 | 0.213 | 0.181 | 0.155 | 0.168 | 0.162 | 0.186 | 0.116 | 0.098 | 0.019 | 0.049 | -0.163 |